Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2021   85,327,000        
Beginning balance at Dec. 31, 2021 $ 1,566,515 $ 853 $ 1,727,667 $ (193,706) $ 9,904 $ 21,797
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 45,703     45,346   357
Unrealized gain (loss) on available-for-sale securities (22,709)       (22,532) (177)
Unrealized gain (loss) on interest rate swaps 289       287 2
Issued shares of common stock (in shares)   1,050,000        
Issued shares of common stock 49,860 $ 10 49,850      
Equity-based compensation 3,541   962     2,579
Issuance (repurchase) of vested equity-based compensation shares (in shares)   60,000        
Issuance (repurchase) of vested equity-based compensation shares (2,211) $ 1 (2,212)      
Conversion of Convertible Notes (in shares)   283,000        
Conversion of Convertible Notes 7,674 $ 3 7,671      
Dividends and distributions (34,668)     (32,922)   (1,746)
Ending balance (in shares) at Mar. 31, 2022   86,720,000        
Ending balance at Mar. 31, 2022 1,613,994 $ 867 1,783,938 (181,282) (12,341) 22,812
Beginning balance (in shares) at Dec. 31, 2021   85,327,000        
Beginning balance at Dec. 31, 2021 $ 1,566,515 $ 853 1,727,667 (193,706) 9,904 21,797
Ending balance (in shares) at Dec. 31, 2022 90,837,008 90,837,000        
Ending balance at Dec. 31, 2022 $ 1,664,746 $ 908 1,924,200 (285,474) (10,397) 35,509
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 24,598     24,106   492
Unrealized gain (loss) on available-for-sale securities 8,875       8,760 115
Unrealized gain (loss) on interest rate swaps (31,768)       (31,183) (585)
Issued shares of common stock (in shares)   763,000        
Issued shares of common stock 23,256 $ 8 23,248      
Equity-based compensation 7,898   774     7,124
Issuance (repurchase) of vested equity-based compensation shares (in shares)   58,000        
Issuance (repurchase) of vested equity-based compensation shares (1,317) $ 1 (1,318)      
Dividends and distributions $ (37,473)     (36,340)   (1,133)
Ending balance (in shares) at Mar. 31, 2023 91,657,822 91,658,000        
Ending balance at Mar. 31, 2023 $ 1,658,815 $ 917 $ 1,946,904 $ (297,708) $ (32,820) $ 41,522